PAVM
PAVmed Inc
Halal Rating :
Last Price
$0.65
Last updated:
Market Cap
-
7D Change
8.18%
1 Year Change
-74.64%
Company Overview
Industries
Exchange
Next Earnings Date
PAVmed Inc. is a medical device company focused on developing and commercializing innovative medical technologies. The company operates through its subsidiaries, including Lucid Diagnostics Inc. and Veris Health Inc. Their product portfolio includes EsoGuard, a DNA test for detecting esophageal cancer risk, and various other medical devices in development.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $996000.0 | $13.99m | - | $1.42m | 0.00% | 10.12% |
| June 30, 2024 | $979000.0 | $15.44m | - | $774000.0 | 0.00% | 5.01% |
| March 31, 2024 | $1.01m | $17.43m | - | $2.38m | 0.00% | 13.68% |
Company Impact
Help us evaluate PAVmed Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.